Related Experiment Video
Updated: Aug 21, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Extensive right coronary artery thrombosis in a patient with COVID-19: A case report
Clarissa Campo Dall'Orto1, Rubens Pierry Ferreira Lopes2, Mariana Torres Cancela3
1Therapy Center, Brazilian Society of Health Support Hospital, Teixeira de Freitas 45987-088, Bahia, Brazil. clarissadallorto@alumni.usp.br.
Insights
This case study details the first reported instance of right coronary artery thrombosis in a patient with coronavirus disease 2019 (COVID-19). Dual antiplatelet and anticoagulation therapy successfully resolved the extensive thrombi.
Area of Science:
- Cardiology
- Infectious Diseases
- Vascular Medicine
Background:
- Cardiovascular complications are frequent in hospitalized coronavirus disease 2019 (COVID-19) patients, contributing to significant morbidity and mortality.
- Right coronary artery (RCA) thrombosis is a rare but serious complication associated with COVID-19.
Observation:
- A 62-year-old female with COVID-19 presented with symptoms of myocardial infarction, including chest pain and ST-segment elevations.
- Intracoronary imaging (intravascular ultrasound and optical coherence tomography) revealed extensive subacute and acute thrombi in the RCA and its branches, alongside underlying atherosclerosis.
- Invasive physiological assessment using the resting full-cycle ratio showed no significant impairment in coronary flow despite the presence of plaque.
Findings:
- This is the first documented case of extensive RCA thrombosis in a COVID-19 patient, comprehensively evaluated with intracoronary imaging and physiology.
- Dual antiplatelet and anticoagulation therapy led to complete resolution of the coronary thrombi within 7 days.
- The patient remained asymptomatic during a 6-month follow-up period.
Implications:
- This case highlights the potential for severe thrombotic events in the coronary arteries of COVID-19 patients.
- Effective management of COVID-19-associated coronary thrombosis can be achieved with timely dual antiplatelet and anticoagulation therapy.
- Further research is warranted to understand the mechanisms and long-term cardiovascular impact of COVID-19 on coronary vasculature.
Background:
Occurring in approximately 30% of hospitalized patients, cardiovascular complications that take place during the course of coronavirus disease 2019 (COVID-19) have been shown to cause morbidity and mortality. This case is the first report of extensive right coronary artery (RCA) thrombosis that was evaluated by intracoronary imaging and intracoronary invasive physiology in a patient with COVID-19.
Case Summary:
A 62-year-old woman presented with flu-like symptoms; ten days later, she presented with inferior ST-segment elevations, chest pain, dyspnea, nausea and vomiting. The patient was diagnosed with COVID-19 following a positive test result. Emergency angiography of the RCA and its branches indicated intraluminal filling defects, suggesting a thrombus. Intravascular ultrasound confirmed a subacute thrombus in the RCA, the right posterior descending branch and the right posterior ventricular (RPV) branch. There was also an acute thrombus in the RPV branch and atherosclerosis in the RCA. Dual antiplatelet/ anticoagulation therapy was administered. After 7 d, angiography revealed complete disappearance of the thrombi. Optical coherence tomography confirmed this with the exception of a small thrombus in the RPV branch and atherosclerotic plaque in the RCA. The atherosclerotic RCA was measured using the resting full-cycle ratio, indicating no impairment to coronary physiology. The patient was discharged on the 11th day of hospitalization and remained asymptomatic through the 6-mo follow-up.
Conclusion:
This was the first report of RCA thrombosis in a patient with COVID-19. Dual antiplatelet/anticoagulation therapy was successful.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Pericarditis II: Clinical Features and Diagnostic Tests
Coronary Artery Disease II: Pathophysiology